Dermata Therapeutics (DRMA) vs KALA BIO (KALA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
KALA BIO is the larger company by market cap ($5.7 million vs $5.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRMA | KALA |
|---|---|---|
| Share price | $1.07 | $0.2966 |
| Market cap | $5.30M | $5.74M |
| 1-day change | -4.46% | -17.61% |
| EPS (TTM) | $-4.39 | $-10.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.84 | $95.50 |
| 52-week low | $0.951 | $0.2915 |
| Distance from 52-week high | -77.89% | -99.69% |
| Analyst consensus | none | — |
| Avg. price target upside | +273.83% | — |
| Average volume | 708.18K | 1.45M |
| Shares outstanding | 4.96M | 19.34M |
| Employees | 9 | 6 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Dermata Therapeutics
DRMA stock →Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
Healthcare · Biotechnology · 9 employees
About KALA BIO
KALA stock →KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment.
Healthcare · Biotechnology · 6 employees
DRMA vs KALA FAQ
Which is bigger, Dermata Therapeutics or KALA BIO?
KALA BIO (KALA) is larger, with a market capitalization of $5.74M compared with $5.30M for Dermata Therapeutics (DRMA).
Are Dermata Therapeutics and KALA BIO in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.